LabCorp Prices $325 Million in 3.125% Senior Notes Due 2016 and $600 Million in 4.625% Senior Notes Due 2020 Read more about LabCorp Prices $325 Million in 3.125% Senior Notes Due 2016 and $600 Million in 4.625% Senior Notes Due 2020
LabCorp Announces Proposed Sale of up to $925 Million of Senior Notes Read more about LabCorp Announces Proposed Sale of up to $925 Million of Senior Notes
LabCorp is Scheduled to Present at the Credit Suisse 2010 Annual Healthcare Conference Read more about LabCorp is Scheduled to Present at the Credit Suisse 2010 Annual Healthcare Conference
Laboratory Corporation of America(R) Holdings Announces 2010 Third Quarter Results Read more about Laboratory Corporation of America(R) Holdings Announces 2010 Third Quarter Results
Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest Read more about LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
LabCorp Enters into Definitive Agreement to Acquire Genzyme Genetics Read more about LabCorp Enters into Definitive Agreement to Acquire Genzyme Genetics
LabCorp is Scheduled to Present at the Bank of America Merrill Lynch Investment Conference Read more about LabCorp is Scheduled to Present at the Bank of America Merrill Lynch Investment Conference
LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference Read more about LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference
LabCorp Enhances HCV Testing Services with the Launch of IL-28B Test Read more about LabCorp Enhances HCV Testing Services with the Launch of IL-28B Test
